Details

Autor(en) / Beteiligte

• Tay, Tricia
• Somasundaram, Nagavalli
• Lim, Cindy
• Khoo, Lay Poh
• Goh, Allan Zhi Kai
• Lee, Yuh Shan
• Liu, Xin
• Tao, Miriam
• Quek, Richard
• Farid, Mohamad
• Poon, Eileen
• Chan, Jason Y. S.
• Chang, Esther W. Y.
• Yang, Valerie S. W.
• Goh, Yeow Tee
• Tan, Daryl
• Diong, Colin
• Grigoropoulos, Nicholas F.
• Nagarajan, Chandramouli
• Poon, Michelle
• Mel, Sanjay
• Jeyasekharan, Anand
• Chan, Esther H. L.
• Lee, Joanne
• Chee, Yen Lin
• Lim, Soon Thye
• Tang, Tiffany

Titel

Treatment outcomes of T and natural‐killer/T‐cell lymphoma with ifosfamide, carboplatin and etoposide chemotherapy

Ist Teil von

• Cancer reports, 2022-09, Vol.5 (9), p.e1552-n/a

Ort / Verlag

United States: John Wiley & Sons, Inc

Erscheinungsjahr

2022

Quelle

Free E-Journal (出版社公開部分のみ）

Beschreibungen/Notizen

• Background Contemporary data of peripheral T‐cell lymphoma (PTCL) and natural‐killer/T‐cell lymphoma (NKTL) patients treated with ifosfamide, carboplatin and etoposide (ICE) are limited. Aims We performed a retrospective analysis to estimate outcomes of ICE‐treated PTCL and NKTL patients at three tertiary cancer centres in Singapore. Methods and Results Patients were identified through lymphoma databases from National Cancer Centre Singapore (NCCS), National University Hospital, Singapore (NUHS), and Singapore General Hospital (SGH). Responses and survival outcomes were determined from electronic medical records. A total of 75 patients with a median age of 50 were included. ICE was used as first‐line treatment in 14 patients (19%) and as subsequent lines of treatment in 61 patients (81%). The overall response rates (ORR) for all patients was 63% (40% complete response [CR]). The ORR and CR in the first line were 86% and 64% respectively. At a median follow‐up duration of 71.0 months, the median progression‐free (PFS) and overall survival (OS) for all patients were 4.4 months (95%CI, 2.7–6.0) and 16 months (95%CI, 8.3–45.4) respectively. Conclusion In summary, ICE showed high ORR but poor PFS in relapsed/refractory PTCL and NKTL. ORR of ICE in the first line setting appears better than real‐world CHOP data and warrants further study.